Original Research
Published on 14 Oct 2022
World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.979788
- 12,652 views
- 484 citations



